| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 8.8 | 9.8 | 2.8 |
| Other income | 0.1 | 0.7 | 0.4 |
| Total income | 8.9 | 10.5 | 3.2 |
| Profit before exceptional items & tax | 1.1 | 1.6 | -0.1 |
| Exceptional items | 0.0 | -0.1 | 0.0 |
| Profit before tax | 1.1 | 1.5 | -0.1 |
| Net profit | 1.0 | 1.0 | -0.1 |
| Operating margin | 12.4% | 14.3% | -3.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | +0.00% |
|---|---|
| Revenue, year on year | +214.30% |
| Operating profit, year on year | +300.00% |
| Operating profit, quarter on quarter | +11.10% |
BSE results filing, NSE: AUROLAB. Figures extracted from the filing.
Auro Laboratories Ltd: key numbers
- Share price
- ₹232.55
- Market cap
- ₹144.9 Cr
- Revenue (annual)
- ₹32.61 Cr
- Net profit (annual)
- ₹3.53 Cr
- P/E (TTM)
- 30.9×Sector 47.3×
- Promoter holding
- 52.40%+0.22% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Auro Laboratories Ltd
All →Auro Laboratories Annual General Meeting
Auro Laboratories Limited held its 37th Annual General Meeting on August 11, 2026, via video conferencing. The company conducted all items of business as listed in the notice.
Auro Laboratories Board Meeting Date
Auro Laboratories Ltd has scheduled a board meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Auro Laboratories Other Announcement
Auro Laboratories issued a notice to shareholders regarding its 37th AGM scheduled for August 11, 2026. The letter provides web-links to access the FY 2025-26 Annual Report.
Auro Laboratories Annual General Meeting
Auro Laboratories has scheduled its 37th Annual General Meeting for August 11, 2026. Agenda includes adopting financial statements and re-appointing Mr. Kiran Kulkarni as Whole-Time Director.
Auro Laboratories Annual Report
Auro Laboratories released its Annual Report for FY 2025-26. The 37th Annual General Meeting is scheduled for August 11, 2026, via video conferencing.
Auro Laboratories Management Change
Auro Laboratories re-appointed Mr. Kiran Suresh Kulkarni as Whole Time Director. The three-year term starts May 24, 2027, subject to shareholder approval.
- Execution
- 3 years